SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 657.80+1.7%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: BioBait1/24/2021 11:25:07 AM
   of 3557
 
welt.de

Federal government buys antibody funds for GermanyBundesregierung kauft Antikörper-Mittel für Deutschland
The federal government has bought a new antibody-based corona drug for Germany. “From next week, the monoclonal antibodies will be used in Germany as the first country in the EU. First in university clinics, ”said Federal Health Minister Jens Spahn (CDU) of“ Bild am Sonntag ”. "The federal government bought 200,000 cans for 400 million euros."

According to the media report, the former US President Donald Trump was treated with this form of antibodies after his corona infection. “They act like a passive vaccination. The administration of these antibodies can help high-risk patients in the early phase that a severe course is prevented, ”said Spahn.

The then US President Trump was treated with the antibody cocktail REGN-COV2 from the US company Regeneron at the beginning of October. The active ingredient of REGN-COV2 is a combination of two specially developed antibodies that bind to the so-called spike protein of the coronavirus and can thus deform its structure. This is to prevent the coronavirus from attacking human cells. According to Regeneron, the combination of two different antibodies should prevent the Sars-COV2 virus from mutating.

Can't confirm this one? Nothing on the Roche site.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext